Ebola Vaccine Trial Begins in Democratic Republic of Congo

• A late-stage trial for an Ebola vaccine has begun in the Democratic Republic of Congo.
• The vaccine, Ervebo, is approved for use against the Zaire strain and will be tested for cross-protection against Bundibugyo.
• The trial aims to test the safety, efficacy, and immunogenicity of the vaccine.
• The Democratic Republic of Congo is experiencing its most deadly Ebola outbreak, with the death toll nearing 4,700.
• The trial will assess if the vaccine offers any protection against the Bundibugyo strain.